APOE and Alzheimer disease: The significant differences for CSF apoE levels detected between TgF344-AD and controls at 16.5 months of age were maintained when the animals were subgrouped by gender (male: control vs TgF344: p = 0.019; female: control vs TgF344: p = 0.048).